Evolus Inc. EOLS
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Evolus is a performance beauty company specializing in injectable aesthetic products within the global cash-pay aesthetics market across the United States, Canada, Europe, and Australia. The company's flagship product, Jeuveau, is a proprietary botulinum toxin formulation designed to temporarily improve the appearance …
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees350
TickerEOLS
Statistics
Market Cap$448.0M
Revenue (TTM)$297.2M
Net Income-$51.6M
Net Margin-17.4%
EPS$-0.80
P/E-8.13
P/S1.42
P/B-14.73
EV/EBITDA-24.09
ROE223.5%
Dividend Yield—
Price$6.80
Data: Twelve Data · Revenue = mcap / P/S